Prospective randomised trial comparing gonadotrophin‐releasing hormone analogues with triple tourniquets at open myomectomy

Objective  To compare intra‐operative blood loss with triple tourniquets to occlude uterine blood supply against preoperative treatment with gonadotrophin‐releasing hormone (GnRH) analogues at open myomectomy.

[1]  C. Wiysonge,et al.  Interventions to reduce haemorrhage during myomectomy for fibroids. , 2011, The Cochrane database of systematic reviews.

[2]  C. Wiysonge,et al.  A systematic review of randomized controlled trials to reduce hemorrhage during myomectomy for uterine fibroids , 2008, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[3]  Y. Chia,et al.  Intramyometrial injection of vasopressin causes bradycardia and cardiac arrest--report of two cases. , 2006, Acta anaesthesiologica Taiwanica : official journal of the Taiwan Society of Anesthesiologists.

[4]  A. Magos,et al.  Color Doppler evaluation of changes in uterine perfusion induced by the use of an absorbable cervical tourniquet during open myomectomy , 2005, Journal of clinical ultrasound : JCU.

[5]  A. Di Spiezio Sardo,et al.  Surgical and radiological management of uterine fibroids – a UK survey of current consultant practice , 2005, Acta obstetricia et gynecologica Scandinavica.

[6]  A. Di Spiezio Sardo,et al.  Reducing blood loss at open myomectomy using triple tourniquets: A randomised controlled trial , 2005, BJOG : an international journal of obstetrics and gynaecology.

[7]  I. Manyonda,et al.  Reducing blood loss at open myomectomy using triple tourniquet: a randomised controlled trial. , 2005, BJOG : an international journal of obstetrics and gynaecology.

[8]  I. Manyonda,et al.  Pre‐myomectomy uterine artery embolisation minimises operative blood loss , 2004, BJOG : an international journal of obstetrics and gynaecology.

[9]  Peng-Hui Wang,et al.  Combining the uterine depletion procedure and myomectomy may be useful for treating symptomatic fibroids. , 2004, Fertility and sterility.

[10]  H. Celik,et al.  Bilateral ascending uterine artery ligation vs. tourniquet use for hemostasis in cesarean myomectomy. A comparison. , 2003, The Journal of reproductive medicine.

[11]  P. Vercellini,et al.  Gonadotropin-releasing hormone agonist treatment before abdominal myomectomy: a controlled trial. , 2003, Fertility and sterility.

[12]  H. Celik,et al.  Use of a single preoperative dose of misoprostol is efficacious for patients who undergo abdominal myomectomy. , 2003, Fertility and sterility.

[13]  N. Papantoniou,et al.  Use of misoprostol for the termination of second trimester pregnancies , 2001, Archives of Gynecology and Obstetrics.

[14]  A. Lethaby,et al.  Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. , 2000, The Cochrane database of systematic reviews.

[15]  R. Romero,et al.  [Hemolytic-uremic syndrome after myomectomy]. , 2001, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

[16]  C. Chapron,et al.  Recurrence of leiomyomata after myomectomy. , 2000, Human reproduction update.

[17]  T. Tulandi,et al.  Pulmonary edema: a complication of local injection of vasopressin at laparoscopy. , 1996, Fertility and sterility.

[18]  D. Simeon,et al.  A Randomized Comparison of Vasopressin and Tourniquet as Hemostatic Agents During Myomectomy , 1996, Obstetrics and gynecology.

[19]  J. Martin,et al.  Intraoperative myocardial infarction after paracervical vasopressin infiltration. , 1994, Anesthesia and analgesia.

[20]  D. Simeon,et al.  Intramyometrial vasopressin as a haemostatic agent during myomectomy , 1994, British journal of obstetrics and gynaecology.

[21]  D. Graber,et al.  Acute misoprostol toxicity. , 1991, Annals of emergency medicine.

[22]  R. Shaw,et al.  Long‐term follow‐up of patients with uterine fibroids after treatment with the LHRH agonist buserelin , 1989 .

[23]  T. Shawker,et al.  Long-acting gonadotropin hormone-releasing hormone analog used to treat uteri. , 1986, Fertility and sterility.

[24]  Buttram Vc.  Uterine leiomyomata--aetiology, symptomatology and management. , 1986 .

[25]  V. Buttram.  Uterine leiomyomata--aetiology, symptomatology and management. , 1986, Progress in clinical and biological research.